Peter Horak
German Cancer Research Center · 236 works · 5,625 citations · h-index 38
Top works
- Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling
- Sarcoma classification by DNA methylation profiling
- Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
- Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
- NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
- Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
- Precision oncology based on omics data: The NCT Heidelberg experience
- 1490MO CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)
- Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
- Variant classification in precision oncology
- Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer
- Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma
- The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
- In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
- The landscape of chromothripsis across adult cancer types
- Promoter hypermethylation of GSTP1, AR, and 14‐3‐3σ in serum of prostate cancer patients and its clinical relevance
- Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
- Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
- Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
- The German Network for Personalized Medicine to enhance patient care and translational research